Antibody Fc mutants with ablated effector functions
US8961967B2 · kind B2 · utility
26Cited by
3References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 29, 2010 |
| Grant date | Feb 24, 2015 |
| Priority date | — |
| Expiry date | Feb 28, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibody and other Fc-containing molecules with variations in the Fc region reduce binding to Fc gamma receptors and resulting activity and can be used in the treatment of various diseases and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.